NRF2 and FXR dual signaling pathways cooperatively regulate the effects of oleanolic acid on cholestatic liver injury.

[1]  Chunhua Xia,et al.  Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[2]  Yunxia Li,et al.  Advances of natural activators for Nrf2 signaling pathway on cholestatic liver injury protection: A review. , 2021, European journal of pharmacology.

[3]  M. Vinken,et al.  Biomarkers of cholestasis. , 2021, Biomarkers in medicine.

[4]  E. Calabrese,et al.  THE HORMETIC DOSE-RESPONSE MECHANISM: NRF2 ACTIVATION. , 2021, Pharmacological research.

[5]  David E. J. Jones,et al.  Managing cognitive symptoms and fatigue in cholestatic liver disease , 2020, Expert review of gastroenterology & hepatology.

[6]  Arturo Santos,et al.  Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects , 2020, Antioxidants.

[7]  Yu-hui Wei,et al.  Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo. , 2020, European journal of pharmacology.

[8]  Yuan-yi Wei,et al.  Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse liver. , 2020, Experimental cell research.

[9]  G. Hirschfield,et al.  The Pathophysiology of Cholestasis and Its Relevance to Clinical Practice , 2020, Clinical liver disease.

[10]  E. Neumann-Haefelin,et al.  The acetyltransferase p300 regulates NRF2 stability and localization. , 2020, Biochemical and biophysical research communications.

[11]  D. Kleiner,et al.  Liver Histology: Diagnostic and Prognostic Features. , 2020, Clinics in liver disease.

[12]  Xuehua Jiang,et al.  Tanshinone IIA prevents rifampicin‐induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2 , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[13]  Shang Gao,et al.  Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS , 2019, Nature Medicine.

[14]  Ting-ting Li,et al.  Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[15]  Yan Yan,et al.  Phytochemicals protect L02 cells against hepatotoxicity induced by emodin via the Nrf2 signaling pathway. , 2019, Toxicology research.

[16]  Petr Smirnov,et al.  Integrative pharmacogenomics analysis of patient-derived xenografts. , 2019, Cancer research.

[17]  O. Cummings,et al.  Hepatic Autophagy Deficiency Compromises Farnesoid X Receptor Functionality and Causes Cholestatic Injury , 2019, Hepatology.

[18]  S. V. D. van de Graaf,et al.  Developments in bile salt based therapies: A critical overview , 2019, Biochemical pharmacology.

[19]  Johnny C. Hong,et al.  Effects of Hepatic Ischemia-Reperfusion Injuries and NRF2 on Transcriptional Activities of Bile Transporters in Rats. , 2019, The Journal of surgical research.

[20]  G. Gao,et al.  Adeno-associated virus vector as a platform for gene therapy delivery , 2019, Nature Reviews Drug Discovery.

[21]  V. Dirsch,et al.  Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR. , 2018, Biotechnology advances.

[22]  Jie Liu,et al.  Oleanolic acid reprograms the liver to protect against hepatotoxicants, but is hepatotoxic at high doses , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[23]  V. Tsutsumi,et al.  Stevia Prevents Acute and Chronic Liver Injury Induced by Carbon Tetrachloride by Blocking Oxidative Stress through Nrf2 Upregulation , 2018, Oxidative medicine and cellular longevity.

[24]  J. Locker,et al.  β‐Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis , 2018, Hepatology.

[25]  S. Keam,et al.  Obeticholic Acid: First Global Approval , 2016, Drugs.

[26]  A. Sharma,et al.  Ursolic Acid and Oleanolic Acid: Pentacyclic Terpenoids with Promising Anti-Inflammatory Activities. , 2016, Recent patents on inflammation & allergy drug discovery.

[27]  M. Huang,et al.  Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism. , 2015, European journal of pharmacology.

[28]  K. Lindor,et al.  Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. , 2015, Gastroenterology.

[29]  Jie Liu,et al.  Protection against phalloidin-induced liver injury by oleanolic acid involves Nrf2 activation and suppression of Oatp1b2. , 2015, Toxicology letters.

[30]  M. Huang,et al.  Low Dose of Oleanolic Acid Protects against Lithocholic Acid–Induced Cholestasis in Mice: Potential Involvement of Nuclear Factor-E2-Related Factor 2-Mediated Upregulation of Multidrug Resistance-Associated Proteins , 2014, Drug Metabolism and Disposition.

[31]  A. Guillouzo,et al.  Oxidative stress plays a major role in chlorpromazine‐induced cholestasis in human HepaRG cells , 2013, Hepatology.

[32]  S. Ito,et al.  Participation of nuclear factor (erythroid 2‐related), factor 2 in ameliorating lithocholic acid‐induced cholestatic liver injury in mice , 2010, British journal of pharmacology.

[33]  D. Stolz,et al.  Liver‐specific β‐catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis , 2010, Hepatology.

[34]  J. Boyer,et al.  Nuclear factor erythroid 2–related factor 2 is a positive regulator of human bile salt export pump expression , 2009, Hepatology.

[35]  Z. Oltvai,et al.  Shaping specificity in signaling networks , 2007, Nature Genetics.

[36]  Bryan Goodwin,et al.  Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. , 2003, The Journal of clinical investigation.

[37]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.

[38]  D. Häussinger,et al.  Targeting FXR in Cholestasis. , 2019, Handbook of experimental pharmacology.

[39]  V. E. Valdespino-Castillo,et al.  [Cell signaling pathways interaction in cellular proliferation: Potential target for therapeutic interventionism]. , 2015, Cirugia y cirujanos.

[40]  Alain Goossens,et al.  Oleanolic acid. , 2012, Phytochemistry.